Today: 20 March 2026
Subscribe
Browse Category

Japan Economy 6 November 2025 - 10 November 2025

Tokyo Stock Exchange Surges to Record Highs on AI Boom – Inside the Nov 3, 2025 Rally

Nikkei Jumps 635 Points as US Shutdown Deal Nears; Yen Softens, JGB Yields Rise, and 38 Japan Stocks Log All‑Time Highs (Nov. 10, 2025)

Japan’s Nikkei 225 surged 635.39 points to 50,911.76 on Monday after a key U.S. Senate vote signaled progress toward ending the 40-day federal government shutdown. The yen weakened past ¥154 per dollar, and Japanese government bond yields rose to multi-year highs. Tech and cyclical stocks led gains, while defensives lagged. Olympus shares jumped on restructuring news; Honda fell after cutting guidance.
10 November 2025
···
Japan Stock Market Today (10 Nov 2025): Nikkei 225 Jumps 1.26% to 50,911; Topix Gains as Tech Rebounds, Yen Near ¥154, BOJ Signals Hike Debate

Japan Stock Market Today (10 Nov 2025): Nikkei 225 Jumps 1.26% to 50,911; Topix Gains as Tech Rebounds, Yen Near ¥154, BOJ Signals Hike Debate

The Nikkei 225 closed up 1.26% at 50,911.76 on Monday, led by gains in technology and AI-related stocks. The Topix rose 0.56% to 3,317.42. The yen weakened to around 154 per dollar as investors responded to improved US government funding prospects and new Bank of Japan signals on rate policy. Tokyo Electron jumped 4.3%, while Mercari surged over 10% after strong earnings.
10 November 2025
··
Record Highs, $55 B Deals & Data Drama: Wall Street’s Wild Week (Oct 4–5, 2025)

Japan Stocks Today (Nov 6, 2025): Nikkei 225 Rebounds Above 50,800 as Tech and Banks Lead; Yen Holds Near ¥154

The Nikkei 225 jumped 1.3% to 50,883.68 on Thursday, with chip stocks Advantest, Disco, and Lasertec leading gains after Wall Street’s rebound. Market breadth improved, with 987 advancers on the TSE Prime. The yen hovered near 153.8 to the dollar, and the 10-year JGB yield stayed close to 1.68%. Toyota reported a 7% profit drop, while Nissan posted a ¥221.9bn first-half loss.
6 November 2025
·····
1 2 3

Stock Market Today

  • Kessler Topaz Meltzer & Check Files Securities Fraud Class Action Against Soleno Therapeutics
    March 20, 2026, 1:23 PM EDT. Kessler Topaz Meltzer & Check, LLP has filed a securities fraud class action lawsuit against Soleno Therapeutics, Inc. (NASDAQ: SLNO) concerning purchases of SLNO stock between March 26 and November 4, 2025. The lawsuit alleges that Soleno made materially false statements and omissions about safety concerns in its Phase 3 clinical trial for diazoxide choline extended-release tablets used to treat hyperphagia linked to Prader-Willi syndrome. The firm claims the company concealed issues relating to excess fluid retention in trial participants. Investors have until May 5, 2026, to seek lead plaintiff status. The complaint is pending in the U.S. District Court for the Northern District of California under case number 3:26-cv-01979. Investors who suffered losses are urged to contact the law firm for legal options at no cost.
Go toTop